Back to CVE records
Critical 9.1Published Jun 18, 2026

CVE-2026-49454Relyra is a strict-by-default SAML 2.0 Service Provider library for Elixir and Phoenix.

Updated under an hour ago ()

Does this affect you?

It lists no affected products yet. Add what you run and Signals checks it as products are added.

No exploitation reported and no EPSS estimate yet.

Relyra is a strict-by-default SAML 2.0 Service Provider library for Elixir and Phoenix. Versions 1.0.0 and 1.1.0 accept forged SAML signatures because SignatureValue was not cryptographically verified before the library returned a successful authentication result. The XMLDSig trust boundary was incomplete as :public_key.verify over the exclusive-C14N canonicalized SignedInfo was not performed against the configured IdP certificate's public key, DigestValue was not recomputed over the canonicalized referenced element, and canonicalize/2 remained an unused passthrough in the signature-verification path. The result was a structure-only acceptance path where document shape and trust-source rejection could succeed without proving the signature bytes. A forged SignatureValue carrying an attacker-controlled NameID could be accepted as {:ok}. This issue has been fixed in version 1.2.0.

CVSS
9.1 CRITICAL (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
Weakness (CWE)
CWE-287, CWE-347
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
Not loaded for this CVE
Assigned by
Not given
NVD analysis
Deferred
Record last updated
Jun 23, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

No affected products are listed yet.

References

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.